Roadman Investments to buy CBP
Canadian venture capital firm Roadman Investments has agreed to acquire CLOV Biopharma Corp.
Canadian venture capital firm Roadman Investments has agreed to acquire CLOV Biopharma Corp.
Copyright PEI Media
Not for publication, email or dissemination